Thomas McGauley
CIK: 0001550701
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TENAX THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 30, 2026TENX
TENAX THERAPEUTICS, INC.
Exercise(M)DirectStock Option (right to buy)
50K shares- - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
Purchase(P)Direct2K shares at avg. $7.34$15K - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
Purchase(P)Indirect1K shares at avg. $7.35$7K - Nov 17, 2025TENX
TENAX THERAPEUTICS, INC.
Purchase(P)Indirect5K shares at avg. $7.23$36K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 30, 2026 | TENX TENAX THERAPEUTICS, INC. | Exercise(M) Stock Option (right to buy) | 50,000 | - | - | Direct |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase(P) | 2,000 | $7.34 | $14,674 | Direct |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase(P) | 1,000 | $7.35 | $7,350 | Indirect |
| Nov 17, 2025 | TENX TENAX THERAPEUTICS, INC. | Purchase(P) | 5,000 | $7.23 | $36,140 | Indirect |
1-4 of 4 transactions
About MCGAULEY THOMAS
MCGAULEY THOMAS (SEC CIK 0001550701) files insider reports with the SEC as Interim CFO of TENAX THERAPEUTICS, INC. (TENX).
Signal8 holds 3 ownership filings by MCGAULEY THOMAS (1 Form 3, 2 Form 4), filed between Dec 6, 2024 and Feb 3, 2026. Those filings report 4 transactions, from Nov 17, 2025 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MCGAULEY THOMAS's filings is in CHAPEL HILL, NC.
Recent filings by MCGAULEY THOMAS
Other insiders filing for TENAX THERAPEUTICS, INC. (TENX)
- ADAR1 Capital Management, LLC, 10% Owner
- Doogan Declan, Director
- Giordano Christopher Thomas, CEO
- STAAB THOMAS R II, Chief Financial Officer
- Davidson Michael H., Director
- Rich Stuart, Chief Medical Officer